Green Culture Labs co., Ltd

26/02/2026

First Ever Cannabis-Based Medicinal Project in India 🇮🇳

India is launching its first government-supported cannabis medical project in Jammu through a public-private partnership (PPP) led by the CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM) in collaboration with a French company. 

Purpose

• Transform cannabis from a substance associated with abuse into a regulated source of pharmaceutical medicines.

• Develop export-quality medical products derived from cannabis. 

Medical Targets

The project aims to produce cannabinoid-based medicines for:

• Cancer pain management
• Diabetic neuropathy
• Other serious chronic illnesses requiring analgesia 

Project Status

• The initiative has entered Stage 3, with laboratory testing and trials currently underway.

• Human clinical trials are planned as the next step. 

Infrastructure & Investment

• A renovated state-of-the-art research facility has already been completed.

• A new expansion block (~₹55 crore investment, ~8,000 m²) is under construction.

• Facility designed as a green, environmentally focused construction. 

Regulatory Significance

• Special permissions were required because cannabis remains legally classified as a narcotic in India.

• The program represents a shift toward scientific and medical legalization pathways rather than recreational use. 

Strategic Impact

• Intended to position India as a global exporter of cannabis-derived medicines.

• The development model may expand to other Indian states already preparing similar initiatives. 
Takeaway

India is moving cannabis into the pharmaceutical sector by building a government-backed research and production system focused on pain medicines and serious disease treatment, with clinical trials and export markets as the long-term goal.

For decades, India maintained strict regulatory control over cannabis under narcotics law, limiting it largely to traditional or controlled research contexts.

Now, by supporting a formal medical cannabis program through CSIR-Indian Institute of Integrative Medicine, India signals a strategic shift.

As the world’s second-largest pharmaceutical exporter by volume and a global agricultural leader, India is positioning cannabis within a regulated, export-oriented pharmaceutical framework rather than a recreational market model.

February 25, 2026
SOURCE IN COMMENTS

24/02/2026

Cannabidiol and tetrahydrocannabinol in ovarian cancer: Research out of Thailand 🇹🇭

✔️ Study Looked At

• Researchers reviewed multiple studies to understand how cannabis compounds CBD and THC affect ovarian cancer cells

• PRISMA meta-analysis gold standard evidence was gathered and analyzed using the highest methodological transparency.

• The goal was to see whether these plant compounds show real anticancer potential

✔️ Why This Cancer Is Important

• Ovarian cancer is often found late and is difficult to treat

• Many patients develop resistance to chemotherapy, creating a need for new supportive treatments

✔️ Main Findings

• CBD and THC slowed the growth of ovarian cancer cells in laboratory studies

• They triggered programmed cancer cell death

• They reduced processes linked to tumor spread and survival

✔️ How They Work / Mechanisms

• Cannabinoids influence cell signaling that controls inflammation, stress, and tumor metabolism

• They may interfere with pathways cancer cells use to grow and invade nearby tissue

✔️ Combination With Standard Treatment

• Some evidence shows cannabinoids may help chemotherapy work better

• They may reduce drug resistance in cancer cells when used alongside existing treatments

✔️ Important Limitations

• Most evidence comes from lab and preclinical research, not human trials

• Optimal dosing, safety, and delivery methods still need clinical testing

✔️ Bottom Line

• The results are strong and consistent enough to support moving forward into carefully controlled human studies to confirm safety, effectiveness, and real medical benefit.

• Cannabis compounds show promising anticancer effects in early research, but more human studies are needed before they can be used as confirmed medical treatments.

February 20, 2026
SOURCE in comments

21/02/2026

From Fried to FOCUS

After work, Cannabis use and next day job performance: Key Highlights

✔️ Study Approach

• Daily diary research tracking real employee behavior across multiple workdays

• Controlled for sleep, alcohol use, mood, and prior performance

✔️ Core Finding

• After-work cannabis use showed no consistent negative effect on next-day work performance or executive functioning

✔️ Cognitive Outcomes

• No reliable decline in focus, engagement, or task completion was observed

✔️ Context-Dependent Effects

• Workload and personal reasons for use influenced outcomes

• Effects varied between individuals rather than following a single pattern

✔️ Psychological Insight

• Cannabis may function as a recovery behavior helping some workers mentally disengage from stress after work

✔️ Workplace Implication

• Performance outcomes appear shaped more by context and individual differences than cannabis use alone

January 2026
Source / Full article in Comments

20/02/2026

H**p Peptide Boosts Oxygen Use & Quadruples Endurance at High Altitude: Human and Animal Model

H**p Seed Super Food for real.

A new study reveals that a peptide from h**p seeds (edestin) can dramatically improve physical performance under low-oxygen conditions.

The Science:

Researchers tested the peptide (EPP) on mice and humans under simulated high altitude. Results were significant:

• 4x More Endurance: Mice ran four times longer at a 4,000m simulated altitude.

• +15% VO₂ Max: Humans increased maximum oxygen uptake by nearly 15% at 3,600m.

• +41% Tolerance: People could comfortably handle the low-oxygen environment for 41% longer before feeling exhausted or out of breath.

The Bottom Line:

Rich in amino acids and antioxidants, this natural, plant-based peptide offers a promising new way to combat fatigue and enhance performance in harsh, high-altitude environments.

Also suggesting it would be a valuable supplement even without the extreme stress of high altitude.

February 2026
SOURCE to Study in comments

19/02/2026

People Who Switched to Cannabis Drinks Cut Alcohol Use Nearly in Half

A study published in the Journal of Psychoactive Drugs explored whether cannabis infused beverages may help reduce alcohol consumption through a harm reduction approach.

Findings suggest that for some adults, cannabis drinks can function as a practical social substitute while lowering alcohol exposure.

✔️ Study Overview

• Survey of 438 adults who used cannabis within the past year

• First research focused specifically on cannabis beverages as an alcohol harm reduction tool

• Based on real world consumption patterns

✔️ Alcohol Consumption Outcomes

• Average weekly alcohol intake decreased from 7.02 drinks to 3.35 drinks

• Nearly a 50 percent reduction in alcohol use

• Participants reported fewer binge drinking episodes

✔️ Behavioral Substitution

• 62.6 percent reduced or stopped alcohol use after starting cannabis drinks

• 58.6 percent intentionally substituted cannabis for alcohol

• Higher substitution rates than other cannabis formats

✔️ Why Beverage Format Matters

• Drinking behavior is strongly tied to social rituals

• Beverage format mirrors alcohol use in social environments

• Allows participation without ethanol exposure

✔️ Product Observations

• Most beverages contained 10 mg cannabidiol or less

• Many consumers did not know cannabinoid content highlighting labeling needs

✔️ Public Health Context

• Alcohol is linked to multiple cancers and nearly 200 diseases

• Harm reduction aims to lower risk rather than require abstinence

• Cannabis beverages may provide a lower risk alternative for some adults

✔️ Why It Matters

The findings suggest behavioral experience plays a major role in substance choice. Cannabis beverages may reduce alcohol related harm by preserving social interaction while replacing alcohol consumption.

February 17, 2026
SOURCE IN COMMENT

—————————————————
—————————————————
Disclaimer: All shared content is for Awareness, Academic, and Discussion Purposes Only.

This page does not provide Medical Advice, Endorse Specific Treatments and/or Substances NOT legally Approved by Public Health Authorities / Agencies

Content Consists of Most Up to Date News Articles - Scientific Summaries on People and Planet

18+ ONLY | Viewers Discretion is Advised

Join Growing Community Raising Awareness, Increase Educational Capacity, and High iQ-uality Discussions

Cost You Nothing — Gain Valuable Knowledge Join Growing Community Here ⬇️ Review

Green Culture Labs co., Ltd

19/02/2026

Psilocybin Microdosing May Restore Brain Function Without Hallucinations

New research published in Neuropsychopharmacology shows that low-dose psilocybin reversed cognitive deficits in a Fragile X Syndrome (FXS) model — the leading inherited cause of intellectual disability and a major genetic contributor to autism.

✔️ The key discovery:

the benefits were not driven by hallucinogenic serotonin signaling, but by activation of the BDNF–TrkB pathway, a central mechanism responsible for neuroplasticity, synaptic repair, and learning.

This finding suggests therapeutic brain benefits may be separated from psychedelic effects — a critical step toward safer, mechanism-based treatments.

✔️ Why this matters

• Fragile X Syndrome affects about 1 in 4,000 males and 1 in 8,000 females worldwide

• Autism Spectrum Disorder affects roughly 1 in 31 children in the United States, with FXS accounting for up to 6 percent of cases

• According to RAND research, approximately 11 million Americans used psilocybin in 2025, with many reporting microdosing

✔️ Why people microdose

• Managing anxiety and depression

• Improving mood and emotional stability

• Enhancing focus and creativity

• Supporting sleep and overall well-being

• Promoting healthier lifestyle behaviors

If these results translate to humans, psychedelic science may be entering a new phase — targeting neuroplasticity to restore cognitive function while minimizing psychoactive burden.

February 13, 2026
SOURCE (s) / full article in Comments

—————————————————
—————————————————
Disclaimer: All shared content is for Awareness, Academic, and Discussion Purposes Only.

This page does not provide Medical Advice, Endorse Specific Treatments and/or Substances NOT legally Approved by Public Health Authorities / Agencies

Content Consists of Most Up to Date News Articles - Scientific Summaries on People and Planet

18+ ONLY | Viewers Discretion is Advised

Join Growing Community Raising Awareness, Increase Educational Capacity, and High iQ-uality Discussions

Cost You Nothing — Gain Valuable Knowledge Join Growing Community Here ⬇️ Review

18/02/2026

How Compound(s) in Cannabis could Be the Key to treating Obesity

New research suggests that cannabigerol (CBG), a major component found in h**p, might help tackle obesity in a completely new way.

Researchers discovered that extracts from CBG-dominant cannabis flowers can actually "reprogram" fat cells. In lab tests, these extracts did three important things:

✔️ Blocked fat cell formation (stopping fat from being created)

✔️ Increased fat burning (helping cells break down existing fat)

✔️ Promoted "good" fat (turning energy-storing white fat into energy-burning beige fat)

The most potent extract was made with high-proof alcohol (99.5%), which pulled the highest amount of beneficial cannabinoids from the plant.

The effects got stronger as the concentration of the extract increased.

While this is early-stage lab research, it opens the door for developing new, plant-based approaches to weight management that target metabolism from multiple angles — without the harsh side effects of some current medications.

✔️ Other study on THCV for appetite suppression.

CBG vs. THCV for Weight Management

• Primary Mechanism: CBG acts on fat cells (adipogenesis, browning) THCV acts on the brain/CB1 receptors (appetite suppression)

• Key Effect: CBG reprograms fat storage to fat burning; THCV reduces hunger and improves insulin sensitivity.

• Research Stage: CBG is in early lab/cell studies; THCV has progressed to human clinical trials

• Appetite Impact: CBG has an indirect effect via metabolism; THCV has a direct appetite-suppressing effect

February 2026
SOURCE(s) in Comments

17/02/2026

17/02/2026

HAPPY LUNAR NEW YEAR – YEAR OF THE HORSE

As we welcome the Lunar New Year, may the Year of the Horse bring strength, endurance, prosperity, and forward momentum to all.

The Horse symbolizes determination, progress, and the courage to move boldly toward new opportunities.

May this new year inspire success, innovation, good health, and prosperity for you, your families, and your communities.

At GREEN CULTURE Labs Co., Ltd., we are grateful for the continued support of our partners, communities, and global network.

Wishing everyone abundance, happiness, longevity, and success throughout the Lunar New Year.

福 Happy Lunar New Year From GREEN CULTURE Labs Co., Ltd to our Community!!

Join GCL Here
Green Culture Labs co., Ltd

FEBRUARY 17, 2026

17/02/2026

How CBD + CBC was used and tested against Drug Resistant Breast Cancer

Non Psychoactive Cannabinoids CBC and CBD Demonstrate Synergistic Antitumor Activity Against Drug Resistant Triple Negative Breast Cancer

✔️ Key Scientific Findings

• CBC plus CBD synergistically killed doxorubicin resistant TNBC cells confirmed by combination index analysis

• Treatment reduced tumor cell invasiveness by approximately 55 percent in lab assays

• In mouse models the dual therapy reduced tumor volume by two fold versus single agents and four fold versus controls

• Therapy simultaneously inhibits multiple cancer pathways including MEK ERK PI3K AKT mTOR and NF kB

• Downregulated Cyclin D1 CDK6 and SOD2 proteins critical for cancer proliferation

✔️ Pharmacological Advantage

• Co administration increased drug concentration and total exposure without altering absorption timing

• Computer modeling predicted enhanced absorption in the small intestine when cannabinoids are combined

✔️ Clinical Context

• Triple negative breast cancer lacks targeted treatment options and doxorubicin resistance compromises outcomes

• CBC and CBD showed safety in non cancer cells suggesting potential therapeutic window

• Study provides first preclinical evidence supporting cannabinoid combinations for drug resistant cancers

• Human trials needed to determine clinical applicability

February 2026
SOURCE in Comments

For More Up to Date Scientific Summary on Beneficial Botanicals and Fungi Join Here
Green Culture Labs co., Ltd

16/02/2026

Thai Herbal Cannabis For Anti-Aging : From Ancient Elixirs to Modern Science Validation

For centuries, Thai traditional 🇹🇭medicine utilized complex polypharmacology.

Modern research now confirms these formulas contain potent bioactives that modulate oxidative stress, inflammatory signaling, and tissue regeneration.

🔬 Mechanistic Profiles of Key Remedies

✔️ Phontecho Remedy:

Demonstrates high antioxidant capacity (DPPH IC_{50}: 50.33 \mu g/mL). Its synergy of THCV, CBDV, and Quercetin suggests a multi-pathway mechanism for mitochondrial protection and neuroprotection.

✔️ Belog Plus (BP) Formula:

Directly suppresses iNOS and COX-2 expression. These are the primary enzymes driving chronic "inflammaging" and degenerative cellular decay.

✔️ Cannabis Leaf Extract (CLES):

Protects the dermal matrix by inhibiting UVA-induced MMP-1 collagen degradation. It represents a significant candidate for anti-photoaging cosmeceuticals.

✔️ Akineewakana Recipe:

This historic formula (King Narai era) utilizes high phenolic concentrations to achieve rapid radical scavenging (ABTS IC_{50}: 23.39 \mu g/mL).


✔️ Cannabis Stem Extract:

Exhibits powerful Tyrosinase inhibition (IC_{50}: 0.01 mg/mL) and 5-LOX suppression, offering pathways for pigmentation control and anti-inflammatory therapy.

🧠 Translational & Clinical Significance

These findings redefine Thai cannabis medicine as a pre-optimized drug discovery platform.

Unlike single-molecule isolates, these formulations interact with complex biological networks to provide:

✔️ Systemic Antioxidant Defense: Activation of the Nrf2-ARE pathway.

✔️ Cytokine Regulation: Downregulation of pro-inflammatory markers (IL-6).

✔️ Tissue Preservation: Inhibition of collagen-destroying enzymes.

By utilizing markers like Gallic acid, γ-sitosterol, and minor cannabinoids, these ancient recipes are being standardized into modern, evidence-based therapies for longevity and metabolic health.

SOURCE in comments

—————————————————
—————————————————
Disclaimer: All shared content is for Awareness, Academic, and Discussion Purposes Only.

This page does not provide Medical Advice, Endorse Specific Treatments and/or Substances NOT legally Approved by Public Health Authorities / Agencies

Content Consists of Most Up to Date News Articles - Scientific Summaries on People and Planet

18+ ONLY | Viewers Discretion is Advised

Join Growing Community Raising Awareness, Increase Educational Capacity, and High iQ-uality Discussions

Cost You Nothing — Gain Valuable Knowledge Join Growing Community Here ⬇️ Review
Green Culture Labs co., Ltd